2023 年回顾：用于 COVID-19 的高流量鼻导管。

IF 2.4 4区医学 Q2 CRITICAL CARE MEDICINE

Respiratory care Pub Date : 2024-11-18 DOI:10.4187/respcare.12580

Michael D Davis

{"title":"2023 年回顾：用于 COVID-19 的高流量鼻导管。","authors":"Michael D Davis","doi":"10.4187/respcare.12580","DOIUrl":null,"url":null,"abstract":"COVID-19, caused by SARS-CoV-2 infection, led to a pandemic of acute respiratory illness that is ongoing. High-flow nasal cannula (HFNC) is a commonly used form of respiratory support during acute respiratory distress and is used to treat patients with COVID-19 in many centers. Due to the novel nature of COVID-19 at the onset of the pandemic, evidence to support the use and best practices of HFNC for treating patients with COVID-19 was lacking. This is a review of key peer-reviewed manuscripts from 2022-2023 discussing the efficacy and best practices for using HFNC for patients with COVID-19. Efficacy of HFNC for COVID-19, the use of the respiratory oxygenation index to guide HFNC for COVID-19, and concerns of generated/fugitive aerosols when using HFNC for COVID-19 are emphasized.","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":"69 12","pages":"1587-1591"},"PeriodicalIF":2.4000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572994/pdf/","citationCount":"0","resultStr":"{\"title\":\"2023 Year in Review: High-Flow Nasal Cannula for COVID-19.\",\"authors\":\"Michael D Davis\",\"doi\":\"10.4187/respcare.12580\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"COVID-19, caused by SARS-CoV-2 infection, led to a pandemic of acute respiratory illness that is ongoing. High-flow nasal cannula (HFNC) is a commonly used form of respiratory support during acute respiratory distress and is used to treat patients with COVID-19 in many centers. Due to the novel nature of COVID-19 at the onset of the pandemic, evidence to support the use and best practices of HFNC for treating patients with COVID-19 was lacking. This is a review of key peer-reviewed manuscripts from 2022-2023 discussing the efficacy and best practices for using HFNC for patients with COVID-19. Efficacy of HFNC for COVID-19, the use of the respiratory oxygenation index to guide HFNC for COVID-19, and concerns of generated/fugitive aerosols when using HFNC for COVID-19 are emphasized.\",\"PeriodicalId\":21125,\"journal\":{\"name\":\"Respiratory care\",\"volume\":\"69 12\",\"pages\":\"1587-1591\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-11-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572994/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Respiratory care\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4187/respcare.12580\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4187/respcare.12580","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}

引用次数: 0

摘要

由 SARS-CoV-2 感染引起的 COVID-19 导致急性呼吸道疾病大流行，目前仍在持续。高流量鼻插管（HFNC）是急性呼吸窘迫期间常用的一种呼吸支持方式，许多中心都用它来治疗 COVID-19 患者。由于 COVID-19 在大流行之初是一种新型病毒，因此在治疗 COVID-19 患者时缺乏支持使用 HFNC 和最佳实践的证据。本文回顾了2022-2023年经同行评审的主要手稿，讨论了使用HFNC治疗COVID-19患者的疗效和最佳实践。其中强调了HFNC治疗COVID-19的疗效、使用呼吸氧合指数指导HFNC治疗COVID-19，以及使用HFNC治疗COVID-19时对产生/飞散气溶胶的担忧。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

2023 Year in Review: High-Flow Nasal Cannula for COVID-19.

COVID-19, caused by SARS-CoV-2 infection, led to a pandemic of acute respiratory illness that is ongoing. High-flow nasal cannula (HFNC) is a commonly used form of respiratory support during acute respiratory distress and is used to treat patients with COVID-19 in many centers. Due to the novel nature of COVID-19 at the onset of the pandemic, evidence to support the use and best practices of HFNC for treating patients with COVID-19 was lacking. This is a review of key peer-reviewed manuscripts from 2022-2023 discussing the efficacy and best practices for using HFNC for patients with COVID-19. Efficacy of HFNC for COVID-19, the use of the respiratory oxygenation index to guide HFNC for COVID-19, and concerns of generated/fugitive aerosols when using HFNC for COVID-19 are emphasized.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Respiratory care 医学-呼吸系统

CiteScore

4.70

自引率

16.00%

发文量

209

审稿时长

1 months

期刊介绍： RESPIRATORY CARE is the official monthly science journal of the American Association for Respiratory Care. It is indexed in PubMed and included in ISI''s Web of Science.